Table 2. ERα and PR expression profiles in all patients.
Intensity | Distribution | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Marker | Positive | Weak | Moderate | Strong | Focal | Diffuse | ||||||
N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | |
ERα (n = 913) | ||||||||||||
Nucleus | 157 | (17) | 118 | (75) | 27 | (17) | 12 | (8) | 138 | (88) | 19 | (12) |
Cytoplasm | 86 | (9) | 80 | (93) | 6 | (7) | 0 | (0) | 74 | (86) | 12 | (14) |
PR (n = 910) | ||||||||||||
Nucleus | 119 | (13) | 93 | (78) | 20 | (17) | 6 | (5) | 108 | (91) | 11 | (9) |
Cytoplasm | 116 | (13) | 87 | (75) | 21 | (18) | 8 | (7) | 80 | (69) | 36 | (31) |
ER, estrogen receptor; PR, progesterone receptor